Skip to main content
ArticleOPEN ACCESS

Author Correction: The current landscape of nucleic acid therapeutics (Nature Nanotechnology, (2021), 16, 6, (630-643), 10.1038/s41565-021-00898-0)

Nature Nanotechnology
DOI: 10.1038/s41565-021-00937-w
14Citations
Citations of this article
120Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In Table 2 of the version of this Review originally published, the nucleic acid therapeutic ‘Nedosiran’ was incorrectly listed as a GalNAc– ASO conjugate, but it is a GalNAc–siRNA conjugate. Table 2 has now been amended accordingly in the online versions of the Review.

Cite

CITATION STYLE

APA

Kulkarni, J. A., Witzigmann, D., Thomson, S. B., Chen, S., Leavitt, B. R., Cullis, P. R., & van der Meel, R. (2021, July 1). Author Correction: The current landscape of nucleic acid therapeutics (Nature Nanotechnology, (2021), 16, 6, (630-643), 10.1038/s41565-021-00898-0). Nature Nanotechnology. Nature Research. https://doi.org/10.1038/s41565-021-00937-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free